UNSPSC 51101931: Quinocide

This classification denotes an antimalarial agent with the molecular formula C15H21N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CNG7995Y4B, chemically known as 1,4-pentanediamine, n1-(6-methoxy-8-quinolinyl)- (9ci) but generally known as quinocide, which bears US NIH Compound Identifier 68928. European Medicines Agency schedules Quinocide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10219MIG.

UNSPSC 51101931 Quinocide is a Commodity code under which state and local governments procure pharmaceutical products, specifically antimicrobial and emergency-response medications for public health and emergency preparedness initiatives. Recent solicitations show state and local agencies buying branded and generic pharmaceutical inventory to support departmental stockpiling, community health programs, and emergency medical response systems. The issuing bodies include state departments of public health and county public health and emergency management offices, which use both direct purchasing and cooperative purchasing vehicles—particularly multi-state pharmaceutical consortiums such as MMCAP Infuse—to aggregate demand and access pre-negotiated pricing from established pharmaceutical distributors and contract manufacturers.

Recent activity appears concentrated in the Southeast and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 (IFB 26482DPHPREPDB53392, response date September 11, 2026) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with a 12-month initial term and two renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS, posted June 30, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries; the county required electronic bid submission through its e-Procurement Portal and compliance with drug-free workplace certification and E-Verify. Cooperative purchasing vehicles and piggyback contracts appear to dominate the procurement method for larger state-level pharmaceutical orders, while county-level solicitations tend toward competitive sealed bidding with annual renewal options.